Cargando…
Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells
Dynorphin 1–17, (DYN 1–17) opioid peptide produces antinociception following binding to the kappa-opioid peptide (KOP) receptor. Upon synthesis and release in inflamed tissues by immune cells, DYN 1–17 undergoes rapid biotransformation and yields a unique set of opioid and non-opioid fragments. Some...
Autores principales: | Fazalul Rahiman, Siti Sarah, Morgan, Michael, Gray, Paul, Shaw, Paul Nicholas, Cabot, Peter John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824444/ https://www.ncbi.nlm.nih.gov/pubmed/27055013 http://dx.doi.org/10.1371/journal.pone.0153005 |
Ejemplares similares
-
Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B
por: Tran, Thi A., et al.
Publicado: (2011) -
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
Publicado: (1991) -
Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer
por: Wang, Xin, et al.
Publicado: (2022) -
Tumour Necrosis Factor-alpha and Nuclear Factor-kappa B Gene Variants in Sepsis
por: Acar, Leyla, et al.
Publicado: (2018) -
Relevance of the Kappa Dynorphin System to Schizophrenia and Its Therapeutics
por: Abi-Dargham, Anissa
Publicado: (2021)